193 related articles for article (PubMed ID: 12091353)
1. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
Pan XQ; Zheng X; Shi G; Wang H; Ratnam M; Lee RJ
Blood; 2002 Jul; 100(2):594-602. PubMed ID: 12091353
[TBL] [Abstract][Full Text] [Related]
2. Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid.
Li H; Lu Y; Piao L; Wu J; Liu S; Marcucci G; Ratnam M; Lee RJ
Int J Pharm; 2010 Dec; 402(1-2):57-63. PubMed ID: 20883757
[TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
Qi H; Ratnam M
Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
[TBL] [Abstract][Full Text] [Related]
4. Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells.
Lu Y; Wu J; Wu J; Gonit M; Yang X; Lee A; Xiang G; Li H; Liu S; Marcucci G; Ratnam M; Lee RJ
Mol Pharm; 2007; 4(5):707-12. PubMed ID: 17708654
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
Pan XQ; Wang H; Lee RJ
Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
[TBL] [Abstract][Full Text] [Related]
6. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model.
Pan XQ; Lee RJ
Anticancer Res; 2005; 25(1A):343-6. PubMed ID: 15816557
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites.
Hao H; Qi H; Ratnam M
Blood; 2003 Jun; 101(11):4551-60. PubMed ID: 12543860
[TBL] [Abstract][Full Text] [Related]
8. Receptor induction and targeted drug delivery: a new antileukaemia strategy.
Ratnam M; Hao H; Zheng X; Wang H; Qi H; Lee R; Pan X
Expert Opin Biol Ther; 2003 Jul; 3(4):563-74. PubMed ID: 12831362
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia.
Wang H; Zheng X; Behm FG; Ratnam M
Blood; 2000 Nov; 96(10):3529-36. PubMed ID: 11071651
[TBL] [Abstract][Full Text] [Related]
10. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor.
Wang X; Jansen G; Fan J; Kohler WJ; Ross JF; Schornagel J; Ratnam M
Biochemistry; 1996 Dec; 35(50):16305-12. PubMed ID: 8973205
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
[TBL] [Abstract][Full Text] [Related]
12. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid is capable of inducing folate receptor β expression in KG-1 cells.
Xu Y; Wang T; Tang R; Tang S
Tumour Biol; 2010 Dec; 31(6):589-95. PubMed ID: 20632143
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
Ni S; Stephenson SM; Lee RJ
Anticancer Res; 2002; 22(4):2131-5. PubMed ID: 12174894
[TBL] [Abstract][Full Text] [Related]
15. Targeted drug delivery via folate receptors.
Zhao X; Li H; Lee RJ
Expert Opin Drug Deliv; 2008 Mar; 5(3):309-19. PubMed ID: 18318652
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity.
Shen F; Ross JF; Wang X; Ratnam M
Biochemistry; 1994 Feb; 33(5):1209-15. PubMed ID: 8110752
[TBL] [Abstract][Full Text] [Related]
17. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
[TBL] [Abstract][Full Text] [Related]
18. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro.
Lee RJ; Low PS
Biochim Biophys Acta; 1995 Feb; 1233(2):134-44. PubMed ID: 7865538
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.
Ross JF; Wang H; Behm FG; Mathew P; Wu M; Booth R; Ratnam M
Cancer; 1999 Jan; 85(2):348-57. PubMed ID: 10023702
[TBL] [Abstract][Full Text] [Related]
20. Delivery of calf thymus DNA to tumor by folate receptor targeted cationic liposomes.
Li H; Piao L; Yu B; Yung BC; Zhang W; Wang PG; Lee JL; Lee RJ
Biomaterials; 2011 Sep; 32(27):6614-20. PubMed ID: 21665267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
